PhD in Pharmaceutical Sciences from Oregon State University, my research centers on utilizing bioinformatics and genomics for the genome-guided discovery of novel agents against drug-resistant bacteria, specifically those with Extended Spectrum Beta-Lactamase (ESBL) and Metallo-Beta-Lactamase (MBL) enzymes. I serve as a scientific counselor for the Medicinal, Aromatic and Poisonous Plant Research Center at King Saud University and am actively engaged with several professional organizations, including the American Society of Pharmacognosy and the European Society of Clinical Microbiology and Infectious Diseases. My background in drug discovery and biotechnology has enabled me to supervise various laboratories and classes, mentor students, and contribute to the field through publications and collaborative research endeavors. I aim to advance pharmaceutical sciences and address the challenge of antibiotic resistance
areas of expertise
Bioinformatics Proficiency: Skilled in bioinformatics tools and software for genomic data analysis, enabling the identification and characterization of novel microbial strains and resistance genes.
Genomic Sequencing: Experienced in next-generation sequencing (NGS) techniques and data interpretation, facilitating genome-guided research.
Microbial Cultivation: Proficient in isolating and culturing diverse microbial communities for bioremediation studies.
Analytical Techniques: Familiar with molecular biology techniques such as PCR, qPCR, and cloning, as well as biochemical assays for evaluating microbial activity in bioremediation.
Research Methodology: Strong background in experimental design, data analysis, and statistics for hypothesis-driven research.